Stay up-to-date with the latest developments in securities law through access to both news and all statutes and regulations. Find relevant corporate filings through a searchable EDGAR database. And...
A lawyer who represented King Pharmaceuticals Inc. in a patent case was convicted March 15 on charges he tipped off his financial adviser to the company’s pending $3.6 billion acquisition by Pfizer Inc. ( United States v. Schulman , E.D.N.Y., No. 2:16-cr-00442, jury verdict 3/15/17 ).
A jury in the U.S. District Court for the Eastern District of New York found Robert Schulman of McLean, Va., guilty on securities fraud and conspiracy charges after a trial that began March 7. Schulman represented King in a patent case against Purdue Pharma LP as a lawyer with Hunton & Williams LLP, where he’d worked since 2000. He moved to Arent Fox LLP in Washington in 2013.
The district court’s ruling earlier this year in favor of the government on its theory of prosecution was one of the first to construe a recent U.S. Supreme Court opinion on insider trading liability.
An indictment unsealed in August charged Schulman with tipping off his investment adviser, Tibor Klein of Klein Financial Services in Valley Stream, N.Y., about the Pfizer takeover plan over dinner in August 2010 after having learned of it from another Hunton lawyer.
During the dinner, Schulman had several glasses of wine, and, intoxicated, “blurted out to Klein, ‘It would be nice to be King for a day,’ ” according to a September 2013 Securities and Exchange Commission civil complaint against Klein.
Schulman “intended to imply that he was a ‘big shot’ who knew ‘some kind of information’ ” about King, the SEC alleged.
Klein traded on the information for Schulman, himself and other clients, reaping $428,000 in profits after the takeover was announced in October 2010, according to the indictment. Schulman made $15,500 on the trades and Klein made $36,800, including a surreptitious $28,000 share of profits made by a co-conspirator identified as Klein’s best friend, prosecutors said.
Charges remain pending against Klein, whose trial is slated to begin Sept. 18.
The co-conspirator, Michael Shechtman, pleaded guilty to securities fraud conspiracy in November 2014 and was ordered in May 2015 to forfeit $109,000, the amount prosecutors said he had gained from his trades. He hasn’t been sentenced.
In February, the court said prosecutors could try to show that Schulman’s tip was intended as a gift, even though that wasn’t specifically alleged in the indictment. The decision was one of the first to construe a high court ruling that confidential information given as a gift can trigger insider trading liability. Schulman had moved to preclude the government from pursuing the gift theory at trial.
The SEC case against Klein is on hold pending the outcome of the parallel criminal proceeding.
Defense attorneys for Schulman didn’t respond March 16 to a request for comment. Post-trial defense motions are due April 14.
A spokesman for Arent Fox, in a statement, said that Schulman “is no longer a member” of the firm. He had been on a leave of absence “to focus on personal matters,” he said, adding: “As one of the country’s top general practice firms, Arent Fox is committed to exceeding the industry standards for ethical and professional conduct.”
To contact the reporter on this story: John Herzfeld in New York at firstname.lastname@example.org
Copyright © 2017 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)